Diversity, Equity, and Inclusion in Clinical Trials

被引：2

作者：

Keegan, Grace ^{[1
]}

Crown, Angelena ^{[2
]}

Joseph, Kathie-Ann ^{[3
,4
,5
]}

机构：

[1] Keegan Univ Chicago, Pritzker Sch Med, 924 E 57th St, Chicago, IL 60637 USA

[2] Swedish Canc Inst, True Family Womens Canc Ctr, Breast Surg, Seattle, WA USA

[3] NYU, Grossman Sch Med, NYC Hlth & Hosp Bellevue, Dept Surg, New York, NY USA

[4] NYU, Langone Hlth Inst Excellence Hlth Equity, 180 Madison Ave, New York, NY USA

[5] NYU, Grossman Sch Med, Dept Surg, 424 East 34th St, Kimmel Pavil, KP-3 Room 3-102, New York, NY 10016 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 32卷 / 01期

关键词：

Minority groups; Vulnerable populations; Diversity; Equity; Inclusion; Clinical trials; NEGATIVE BREAST-CANCER; OLDER-ADULTS; RACIAL CONCORDANCE; AFRICAN-AMERICANS; PARTICIPATION; RECRUITMENT; RACE; PHYSICIAN; CHEMOTHERAPY; STRATEGIES;

D O I：

10.1016/j.soc.2022.08.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In summary, minority groups are vastly underrepresented in clinical trial participants and leadership. Because these studies provide innovative and revolutionary treatment options to patients with cancer and have the potential to extend survival, it is imperative that public and private stakeholders, as well as hospital and clinical trial leadership, prioritize equity and inclusion of diverse populations in clinical trial development and recruitment strategies. Achieving equity in clinical trials could be an important step in reducing the overall cancer burden and mortality disparities in vulnerable populations.

引用

页码：221 / 232

页数：12

共 50 条

[31] Using Accreditation to Transform Diversity, Equity, and Inclusion Efforts Into Diversity, Equity, and Inclusion Systems
Nora, Lois Margaret
ACADEMIC MEDICINE, 2022, 97 (01) : 25 - 29
[32] METHODOLOGICAL CONSIDERATIONS RELATED TO EQUITY, DIVERSITY, AND INCLUSION IN CLINICAL EPIDEMIOLOGY
Cho, Youmin
Shang, Shaomei
Zhou, Weijiao
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 163 : 62 - 69
[33] METHODOLOGICAL CONSIDERATIONS RELATED TO EQUITY, DIVERSITY, AND INCLUSION IN CLINICAL EPIDEMIOLOGY
Erhart, Michael
Mueller, Doreen
Gellert, Paul
O'Sullivan, Julie L.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 173
[34] METHODOLOGICAL CONSIDERATIONS RELATED TO EQUITY, DIVERSITY, AND INCLUSION IN CLINICAL EPIDEMIOLOGY
Richter, Adrian
Ulbricht, Sabina
Brockhaus, Sarah
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 171
[35] Equity, diversity, and inclusion in global cancer clinical trial authorship
Eldridge, Linsey
Ginsburg, Ophira
Gopal, Satish
Odeny, Thomas A.
CANCER, 2023, 129 (18) : 2771 - 2772
[36] TRIALS AND TRIBULATIONS: DIVERSITY AND INCLUSION IN PANCREATIC DUCTAL ADENOCARCINOMA CLINICAL TRIALS
Herremans, Kelly M.
Riner, Andrea N.
Hughes, Steven J.
Trevino, Jose G.
GASTROENTEROLOGY, 2021, 160 (06) : S903 - S903
[37] Diversity and Inclusion in Pancreatic Cancer Clinical Trials COMMENT
Herremans, Kelly M.
Riner, Andrea N.
Winn, Robert A.
Trevino, Jose G.
GASTROENTEROLOGY, 2021, 161 (06) : 1741 - +
[38] Letter from the editor: Diversity and inclusion in clinical trials
Elston, Dirk M.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (05) : 981 - 982
[39] Diversity, equity and inclusion in neurology
不详
NATURE REVIEWS NEUROLOGY, 2024, 20 (04) : 199 - 199
[40] Promoting Diversity, Equity, and Inclusion
Elnicki, Michael
Lopez, Lenny
Conigliaro, Joseph
JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (02) : 163 - 164

← 1 2 3 4 5 →